NMRA

0.310010.66%
JP

Joshua Pinto

President, CEO & Director

Dr. Joshua Pinto, also known as Josh, has been President of Neumora Therapeutics, Inc. from February 14, 2025 and serves as its Chief Executive Officer as well as Director since August 14, 2026. Dr. Pinto joined Neumora in 2021. He served as a Director in the Healthcare Investment Banking Group of Credit Suisse, where he focused on small- and mid-cap life sciences companies. Dr. Pinto served as an Independent Director of Metsera, Inc. since September 2024 until November 13, 2025. While at Credit Suisse, he focused on advising biotech companies on mergers, acquisitions, restructurings, activism and financing. Before Credit Suisse, he worked for Piper Jaffray and at Eli Lilly and Company. He holds a Ph.D. in neuroscience from McMaster University, an MBA in finance from McMaster University and a B.S. in Business Administration and biochemistry from Centenary College of Louisiana.

Positions